CBAK Energy Signs Investment Agreement for 12 GWh Sodium-Ion Battery Project in Nanjing

CBAK Energy announces major Nanjing battery expansion with $1.1 billion in projected annual revenue.

What the company is saying

CBAK Energy Technology Limited has signed an investment agreement with the Nanjing Gaochun Economic Development Zone to develop and manufacture large cylindrical sodium-ion battery cells and integrated battery systems in Nanjing, China. The company frames this as a transformative step in its sodium-ion expansion, emphasizing a planned 12 GWh annual cell production project and a separate 6 GWh expansion at its existing Nanjing facility. Management, led by CEO Zhiguang Hu, highlights strong demand for large cylindrical cells and flexibility to produce either sodium-ion or lithium-ion chemistries, depending on market conditions. The announcement stresses estimated revenue potential—$356 million to $400 million annually from the 6 GWh expansion and $712 million to $741 million from the 12 GWh project—if both operate at full capacity and all output is sold. The company is explicit that the 12 GWh project will proceed in phases, contingent on securing financing and sufficient customer demand. Customer testing of sodium-ion cell samples is ongoing in various applications, but no commercial orders or offtake agreements are disclosed. The tone is confident and growth-oriented, with repeated references to flexibility and market-driven decision-making.

What the data suggests

The disclosed figures show CBAK Energy currently operates 4.5 GWh of annual Model 32140 cell capacity at its Nanjing facility. The company targets a 6 GWh expansion by year-end 2026, which would more than double capacity to 10.5 GWh. At full utilization, this expansion could generate $356 million to $400 million in annual revenue, based on management's estimates. A further 12 GWh project, planned to advance in the second half of 2027 if financing is secured, is projected to add $712 million to $741 million in annual revenue at current lithium-ion cell prices and full sales. These revenue projections are hypothetical and assume full capacity utilization and stable pricing, with no evidence of historical sales, utilization rates, or customer commitments provided. The company is still evaluating production line configurations and has not finalized whether both lines will be Model 60150 or a mix with Model 32140, indicating market and technical uncertainty. Customer testing of sodium-ion cells is underway, but there is no disclosure of qualification outcomes or commercial adoption. All major financial benefits are forward-looking and contingent on successful project execution, financing, and market uptake.

Analysis

The announcement is upbeat, highlighting a signed investment agreement and ambitious expansion plans, but most key claims are forward-looking and contingent on future events. Only the signing of the investment agreement and current 4.5 GWh capacity are realised; all capacity increases, revenue estimates, and production line choices are projections dependent on financing, market demand, and phased development. The largest project (12 GWh) is not expected to advance until the second half of 2027, making benefits long-term. Revenue figures are hypothetical, based on full capacity and current market prices, with no evidence of historical sales, profitability, or customer commitments. The capital intensity is high, with large outlays required before any earnings impact, and no profitability or cash flow metrics are disclosed. The narrative inflates progress by presenting potential revenues and capacity as if they are near-term certainties, despite their speculative nature.

Risk flags

• ●Execution risk is high, as both the 6 GWh and 12 GWh expansions depend on timely construction, equipment installation, and ramp-up to full capacity. Delays or operational issues could materially impact the projected revenue and timeline.
• ●Revenue projections are based on full capacity utilization and current market prices, but there is no evidence of committed customer orders or offtake agreements. If demand falls short or prices decline, actual revenues could be significantly lower than projected.
• ●The 12 GWh project is contingent on securing financing, which is not yet in place. Failure to obtain adequate funding would delay or prevent project execution, directly affecting growth prospects.
• ●The company is still determining the optimal mix of cell models and chemistries for new production lines, reflecting uncertainty about future market demand and technical requirements. This flexibility could lead to delays or suboptimal capital allocation if market trends shift unexpectedly.
• ●Customer testing of sodium-ion cells is ongoing, but there is no disclosure of qualification results or commercial adoption. If testing does not lead to orders, the addressable market for the new capacity may be overestimated.

Bottom line

CBAK Energy is pursuing a major expansion of its battery manufacturing footprint in Nanjing, with plans to more than double current capacity by late 2026 and add a further 12 GWh project starting in 2027, subject to financing. The company projects up to $1.1 billion in combined annual revenue from these expansions at full capacity and current market prices, but these figures are hypothetical and not backed by customer contracts or historical sales data. The path to value realization is long and fraught with execution, financing, and market demand risks. Investors should focus on evidence of secured project financing, signed customer agreements, and successful qualification of sodium-ion products as critical future milestones. The most important takeaway is that while the scale of ambition is clear, the financial upside remains speculative until the company demonstrates actual market traction and project delivery.

Announcement summary

(NASDAQ:CBAT) CBAK Energy Technology Limited announced it has signed an investment agreement with the Nanjing Gaochun Economic Development Zone for the research, development, and manufacture of large cylindrical sodium-ion battery cells and integrated battery systems in Nanjing, Jiangsu Province, China. The project will add 12 gigawatt-hours (GWh) of annual cell production capacity, advancing the company’s previously announced sodium-ion expansion plan. CBAK Energy also targets an additional 6 GWh of annual cell capacity at its existing Nanjing facility by year-end 2026. The company plans to advance the 12 GWh project in the second half of 2027, subject to securing financing. The existing Nanjing facility currently has 4.5 GWh of annual Model 32140 cell capacity. The planned 6 GWh expansion would bring total annual cell capacity at the facility to 10.5 GWh. At full capacity with all output sold, the additional 6 GWh could generate an estimated RMB2.4 billion to RMB2.7 billion (approximately US $356 million to US $400 million) in annual revenue. The company is considering two Model 60150 production lines for the expansion, but may instead install one Model 32140 line and one Model 60150 line depending on market conditions and customer demand. The 12 GWh project’s production lines will be designed to manufacture large cylindrical sodium-ion or lithium-ion cells, with the choice of chemistry determined by market conditions and customer demand. At current lithium-ion cell market prices, the company estimates the 12 GWh project could generate an additional RMB4.8 billion to RMB5.0 billion (approximately US $712 million to US $741 million) in annual revenue at full capacity with all output sold. The project will cover cell manufacturing as well as module and battery pack integration, and development will proceed in phases based on financing, customer demand, and project readiness. Customer testing of CBAK Energy’s sodium-ion cell samples is underway in residential and portable energy storage and electric mobility applications, with additional evaluations for specialty vehicles, start-stop systems, and backup power. Zhiguang Hu, Chief Executive Officer of CBAK Energy, stated that the 6 GWh expansion would more than double annual cell capacity at the existing Nanjing facility and help meet strong demand for large cylindrical cells. He also noted that the 12 GWh investment agreement advances plans for sodium-ion production and that designing the lines to produce lithium-ion cells as well would provide more options to serve customers as demand develops in both markets. The company plans to develop the project in phases, with investment guided by financing availability and customer demand.

Disagree with this article?